BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Celgene (CELG), Sanofi (France) (SAN.PA) Executives Charged With Insider Trading


11/19/2012 12:52:43 PM

Executives at health-care companies Celgene Corp. (CELG), Sanofi (SAN) and Stryker Corp. (SYK) were among six people charged for their alleged roles in an insider-trading ring that prosecutors said generated $1.4 million in illicit profit. John Lazorchak, 42, director of financial reporting at Summit, New Jersey-based Celgene, was at the center of the network and regularly tipped others to nonpublic information on acquisitions, quarterly earnings results and regulatory news, Paul Fishman, the U.S. attorney in New Jersey, said in a statement. Those charged include Mark Cupo, 51, an executive at Sanofi and Lazorchak’s former boss, and Mark Foldy, 42, a marketing executive at Kalamazoo, Michigan-based Stryker Corp. and high school classmate of Lazorchak. Prosecutors also charged Lawrence Grum, 48, and Michael Castelli, 48, who made hundreds of thousands of dollars in profit and tipped friends and family, according to Fishman. “Three of the defendants exploited their access to sensitive, confidential information at two New Jersey-based pharmaceutical companies and a prominent medical technology company,” Fishman said.

Read at BusinessWeek
Read at nj.com
Read at Fox News
Read at Washington Post
Read at Wall Street Journal


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->